Oxeia Biopharmaceuticals
Manufacturing · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
361 Newbury St Ste 500, Boston, Massachu...Phone Number
(617) 991-9150Website
www.oxeiabiopharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Oxeia Biopharmaceuticals
Oxeia Biopharmaceuticals is clinical-stage biotech company developing new therapies for conditions that are defined by deficits in neurocognition from injury, degeneration and aging. They are based in Boston Massachusetts.Explore more
Oxeia Biopharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Oxeia Biopharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Oxeia Biopharmaceuticals launches new products
Check if Oxeia Biopharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Oxeia Biopharmaceuticals
Funding: Get notified immidiatlly once Oxeia Biopharmaceuticals has new funding data
Check out if Oxeia Biopharmaceuticals is spiking on competitors!
Oxeia Biopharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Oxeia Biopharmaceuticals recently announced quarterly report
Click to see if Oxeia Biopharmaceuticals had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Oxeia Biopharmaceuticals
Compare insights from companies similar to Oxeia Biopharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Oxeia Biopharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Oxeia Biopharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Oxeia Biopharmaceuticals.
Oxeia Biopharmaceuticals financials insights
Gather financial insights about Oxeia Biopharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Debt
$15K
Oxeia Biopharmaceuticals Tech Stack
A closer look at the technologies used by Oxeia Biopharmaceuticals
Most Recent Scoops
Initial Public Offering (IPO)
Promotion
Executive Move
Facilities Relocation / Expansion
Facilities Management
New Hire
Executive Move
Oxeia Biopharmaceuticals has announced that Julianne Averill has joined the organization as Chief Financial Officer. Previously, Averill served as Senior Director at Danforth Advisors.
Funding
Oxeia Biopharmaceuticals News & Media
US Navy Rear Admiral Don Plummer Joins Oxeia Biopharma Advisory Board as Military Concussions Remain Critical Challenge
Former Navy SEAL to Help Advance Awareness of Military Brain Injuries and the Need for Effective Concussion Treatment BOSTON, MA, UNITED STATES, June 23, 2026 /EINPresswire.com/ -- Oxeia Biopharmaceuticals, a clinical-stage biotech company developing …NFL’s ALEX SMITH JOINS OXEIA INVESTOR WEBINAR EXPLORING WHAT COULD BECOME THE FIRST FDA-APPROVED CONCUSSION THERAPY
Live June 18 Event Gives Investors Access to a Potential Breakthrough in Brain Injury Treatment BOSTON, MA, UNITED STATES, June 10, 2026 /EINPresswire.com/ -- Oxeia Biopharmaceuticals will host a live investor webinar on June 18, 2026, from 2:00 p.m. to …OXEIA BIOPHARMACEUTICALS NAMED MOST INNOVATIVE mTBI COMPANY 2026
Second Year Running Oxeia is Recognized for its Concussion Drug, OXE103; Award Honors Excellence, Resilience and Innovation BOSTON, MA, UNITED STATES, May 15, 2026 /EINPresswire.com/ -- Global Health & Pharma announced today that Oxeia …Oxeia Biopharmaceuticals Oversubscribes First Crowdfunding Campaign, Extends Round for New Investors
Concussion therapeutics developer surpasses crowdfunding goal reflecting strong investor interest in its clinical-stage ghrelin therapy for persistent symptoms. BOSTON, MA, UNITED STATES, April 8, 2026 /EINPresswire.com/ -- Oxeia Biopharmaceuticals …
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Oxeia Biopharmaceuticals
Sign Up For FreeTo access detailed company insights
Oxeia Biopharmaceuticals is clinical-stage biotech company developing new therapies for conditions that are defined by deficits in neurocognition from injury, degeneration and aging. They are based in Boston Massachusetts.... Read More
